These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4610963)

  • 1. Transketolase activity in red blood cells in chronic uremia.
    Kopple JD; Dirige OV; Jacob M; Wang M; Swendseid ME
    Trans Am Soc Artif Intern Organs; 1972; 18(0):250-6, 266. PubMed ID: 4610963
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythrocyte transketolase activity in dialysis patients with neuropathy.
    Warnock LG; Cullum UX; Stouder DA; Stone WJ
    Biochem Med; 1974 Aug; 10(4):351-9. PubMed ID: 4851900
    [No Abstract]   [Full Text] [Related]  

  • 3. [Catalytic activity of transketolase in erythrocytes in chronic kidney failure].
    Mydlík M; Derzsiová K; Takác M; Szabó T; Dandár V
    Vnitr Lek; 1984 Jul; 30(7):642-8. PubMed ID: 6495664
    [No Abstract]   [Full Text] [Related]  

  • 4. Transketolase inhibition as a mechanism in uremic neuropathy.
    Lange K; Lonergan ET; Semar M; Sterzel RB
    Trans Assoc Am Physicians; 1971; 84():172-81. PubMed ID: 5164301
    [No Abstract]   [Full Text] [Related]  

  • 5. LDH activity of red cells in chronic renal failure.
    Melissinos K; Drivas G; Vlassopoulos K
    Clin Chim Acta; 1972 Aug; 40(1):165-9. PubMed ID: 5056625
    [No Abstract]   [Full Text] [Related]  

  • 6. The presence and toxicity of guanidinoproprionic acid in uremia.
    Shainkin R; Giatt Y; Berlyne GM
    Kidney Int Suppl; 1975 Feb; (3):302-5. PubMed ID: 1057703
    [No Abstract]   [Full Text] [Related]  

  • 7. The catalase activity of erythrocytes in chronic renal failure.
    Melissinos KG; Vlassopoulos K; Drivas G; Tsoukantas A
    Clin Chim Acta; 1976 Jan; 66(2):267-8. PubMed ID: 1245073
    [No Abstract]   [Full Text] [Related]  

  • 8. Erythrocyte transketolase activity in uremia.
    Kuriyama M; Mizuma A; Yokomine R; Igata A; Otuji Y
    Clin Chim Acta; 1980 Dec; 108(2):169-77. PubMed ID: 6256098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of the activity of erythrocyte acid phosphatase in chronic renal failure.
    Melissinos K; Vlassopoulos K; Drivas G; Kourounis G
    Clin Chim Acta; 1973 Jan; 43(2):195-9. PubMed ID: 4265808
    [No Abstract]   [Full Text] [Related]  

  • 10. Transketolase activity in uremia.
    Lonergan ET; Semar M; Lange K
    Arch Intern Med; 1970 Nov; 126(5):851-4. PubMed ID: 5475709
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasmatic and erythrocytic angiotensinase activity in subjects with chronic uremia before and after treatment with dialysis].
    Ripa R; Degli Atti B; Cavagna R
    Minerva Med; 1970 Mar; 61(26):1307-13. PubMed ID: 4314603
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolidase and prolinase activities in the erythrocytes of patients with chronic uremia.
    Gejyo F; Kishore BK; Arakawa M
    Nephron; 1983; 35(1):58-61. PubMed ID: 6888626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transketolase activity in tissues of uremic rats.
    Dirige OV; Jacob M; Wang M; Swendseid ME; Kopple JD
    J Nutr; 1973 Dec; 103(12):1723-6. PubMed ID: 4752975
    [No Abstract]   [Full Text] [Related]  

  • 14. Transketolase inhibition and uremic peripheral sensory neuropathy.
    Egan JD; Wells IC
    J Neurol Sci; 1979 May; 41(3):379-95. PubMed ID: 220393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human erythropoietin improves enzyme activity in erythrocytes of predialysis uremics.
    Pietrzak I; Baczyk K; Kubiak W
    Miner Electrolyte Metab; 1996; 22(1-3):102-5. PubMed ID: 8676797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte transketolase inhibition, neuropathy and uremia.
    Henderson LW
    N Engl J Med; 1971 Jun; 284(25):1435-6. PubMed ID: 4325317
    [No Abstract]   [Full Text] [Related]  

  • 17. Erythrocyte transketolase activity in dialyzed patients. A reversible metabolic lesion of uremia.
    Lonergan ET; Semar M; Sterzel RB; Treser G; Needle MA; Voyles L; Lange K
    N Engl J Med; 1971 Jun; 284(25):1399-403. PubMed ID: 4325316
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of hemodialysis on the inhibition of nervous tissue transketolase and on uremic neuropathy.
    Sterzel RB; Semar M; Lonergan ET; Lange K
    Trans Am Soc Artif Intern Organs; 1971; 17():77-9. PubMed ID: 5158138
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intra-erythrocytic GOT activity in uremia and its behavior following pyridoxine administration].
    Balcke P; Schmidt P; Zazgornik J; Kopsa H
    Klin Wochenschr; 1983 Sep; 61(17):859-63. PubMed ID: 6632728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocyte transketolase activity in patients with chronic renal disease.
    Mestyán I; Jobst K; Hazafi K; Green A
    Acta Med Hung; 1986; 43(3):315-9. PubMed ID: 3588170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.